1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) February 26, 1998
SONUS PHARMACEUTICALS, INC.
(Exact name of Registrant as specified in its charter)
Delaware 0-26866 95-4343413
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No)
22026 20th Avenue, S.E., Suite 102, Bothell, Washington 98021
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (425) 487-9500
------------------------
Not Applicable
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Page 1 of 8
Exhibit Index on Page 4
2
ITEMS 1 THROUGH 4 AND 6 THROUGH 9 NOT APPLICABLE.
ITEM 5 OTHER EVENTS.
Reference is made to the press releases issued to the public by the
registrant on February 26, 1998 and March 16, 1998, the text of which are
attached hereto as Exhibits 99.1 and 99.2, for a description of the events
reported pursuant to this Form 8-K.
Page 2 of 8
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
SONUS PHARMACEUTICALS, INC.
Date: March 18, 1998 By:
-----------------------------
Gregory Sessler
Chief Financial Officer
Page 3 of 8
4
EXHIBIT INDEX
SEQUENTIAL
EXHIBIT NO. DESCRIPTION PAGE NO.
- ----------- ----------- ----------
99.1 Press Release dated February 26, 1998. 5
99.2 Press Release dated March 16, 1998. 7
Page 4 of 8